Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.

Anagnostou VK, Dimou AT, Botsis T, Killiam EJ, Gustavson MD, Homer RJ, Boffa D, Zolota V, Dougenis D, Tanoue L, Gettinger SN, Detterbeck FC, Syrigos KN, Bepler G, Rimm DL.

Cancer. 2012 Mar 15;118(6):1607-18. doi: 10.1002/cncr.26450. Epub 2011 Aug 25.

2.

If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung.

Downey P, Cummins R, Moran M, Gulmann C.

APMIS. 2008 Jun;116(6):526-9.

PMID:
18754327
3.

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.

Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, Arbogast S, Robert F, Schreeder MT, Ross DT.

Mod Pathol. 2009 Aug;22(8):1032-43. doi: 10.1038/modpathol.2009.60. Epub 2009 May 8.

4.

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M.

J Clin Oncol. 2009 Apr 20;27(12):2030-7. doi: 10.1200/JCO.2008.19.4134. Epub 2009 Mar 9.

PMID:
19273703
5.

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN.

Am J Surg Pathol. 2010 Dec;34(12):1805-11. doi: 10.1097/PAS.0b013e3181f7dae3.

PMID:
21107086
6.
7.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

8.

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.

9.
10.

On-the-spot lung cancer differential diagnosis by label-free, molecular vibrational imaging and knowledge-based classification.

Gao L, Li F, Thrall MJ, Yang Y, Xing J, Hammoudi AA, Zhao H, Massoud Y, Cagle PT, Fan Y, Wong KK, Wang Z, Wong ST.

J Biomed Opt. 2011 Sep;16(9):096004. doi: 10.1117/1.3619294.

PMID:
21950918
11.

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.

Brown AF, Sirohi D, Fukuoka J, Cagle PT, Policarpio-Nicolas M, Tacha D, Jagirdar J.

Arch Pathol Lab Med. 2013 Sep;137(9):1274-81. doi: 10.5858/arpa.2012-0635-OA. Epub 2013 Jan 4.

PMID:
23289761
12.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

13.

The prognostic application of cytokeratin typing of nonsmall cell lung carcinoma. A retrospective study.

Cohen R, Guber A, Siegal A, Bruderman I, Huszar M, Yellin A, Marom Z, Geiger B.

Cancer. 1997 Feb 1;79(3):468-73.

PMID:
9028356
14.

Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.

Ocque R, Tochigi N, Ohori NP, Dacic S.

Am J Clin Pathol. 2011 Jul;136(1):81-7. doi: 10.1309/AJCPFKOLGL6PMOF3.

PMID:
21685035
15.

Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.

Lee E, Moon JW, Wang X, Kim C, Li S, Shin BK, Jung W, Kim HK, Kim HK, Lee JY.

Hum Pathol. 2015 Aug;46(8):1111-20. doi: 10.1016/j.humpath.2015.04.009. Epub 2015 May 6.

PMID:
26003479
16.

Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.

Ritter JH, Dresler CM, Wick MR.

Hum Pathol. 1995 Nov;26(11):1227-32.

PMID:
7590697
17.

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G.

Hum Pathol. 2003 Jun;34(6):597-604.

PMID:
12827614
18.

The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.

Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK.

Hum Pathol. 2014 May;45(5):926-34. doi: 10.1016/j.humpath.2014.01.005. Epub 2014 Jan 25.

19.

Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.

Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, Gabbert HE, Sarbia M.

Cancer. 2006 Apr 25;108(2):129-34.

Supplemental Content

Support Center